Literature DB >> 18702629

Masticatory dysfunction in persons with Down's syndrome. Part 1: aetiology and incidence.

D Faulks1, V Collado, M-N Mazille, J-L Veyrune, M Hennequin.   

Abstract

The functional and anatomical characteristics of Down's syndrome have direct repercussions on oral health. Orofacial dysfunction is on account of poor neuromotor control, muscle weakness, dental anomalies, dysmorphology and intercurrent illness. In particular, feeding and swallowing are impaired. The aim of this first article was to summarize the orofacial difficulties encountered by persons with Down's syndrome at all stages of life and to explain their aetiology. Indicators are proposed for the identification of masticatory problems within this population and reduced masticatory efficiency is discussed in relation to repercussions on oral and general health and on the social integration of persons with Down's syndrome. A second article will describe techniques for preventing, treating and compensating for masticatory dysfunction in this population.

Entities:  

Mesh:

Year:  2008        PMID: 18702629     DOI: 10.1111/j.1365-2842.2008.01877.x

Source DB:  PubMed          Journal:  J Oral Rehabil        ISSN: 0305-182X            Impact factor:   3.837


  11 in total

1.  An observational study of adults with Down syndrome eating independently.

Authors:  Christina H Smith; Yafen Teo; Sarah Simpson
Journal:  Dysphagia       Date:  2013-07-17       Impact factor: 3.438

2.  T-helper-related cytokines in gingival crevicular fluid from adolescents with Down syndrome.

Authors:  Georgios Tsilingaridis; Tülay Yucel-Lindberg; Thomas Modéer
Journal:  Clin Oral Investig       Date:  2011-01-08       Impact factor: 3.573

3.  Tongue pressure during swallowing in adults with down syndrome and its relationship with palatal morphology.

Authors:  Megumi Hashimoto; Kazuko Igari; Soshi Hanawa; Ayumi Ito; Atsushi Takahashi; Naoko Ishida; Shigeto Koyama; Takahiro Ono; Keiichi Sasaki
Journal:  Dysphagia       Date:  2014-05-21       Impact factor: 3.438

4.  Influence of prenatal EGCG treatment and Dyrk1a dosage reduction on craniofacial features associated with Down syndrome.

Authors:  Samantha D McElyea; John M Starbuck; Danika M Tumbleson-Brink; Emily Harrington; Joshua D Blazek; Ahmed Ghoneima; Katherine Kula; Randall J Roper
Journal:  Hum Mol Genet       Date:  2016-11-15       Impact factor: 6.150

Review 5.  Neurologic complications of Down syndrome: a systematic review.

Authors:  Jonathan D Santoro; Dania Pagarkar; Duong T Chu; Mattia Rosso; Kelli C Paulsen; Pat Levitt; Michael S Rafii
Journal:  J Neurol       Date:  2020-09-12       Impact factor: 6.682

6.  Non-trisomic homeobox gene expression during craniofacial development in the Ts65Dn mouse model of Down syndrome.

Authors:  Cherie N Billingsley; Jared R Allen; Douglas D Baumann; Samantha L Deitz; Joshua D Blazek; Abby Newbauer; Andrew Darrah; Brad C Long; Brandon Young; Mark Clement; R W Doerge; Randall J Roper
Journal:  Am J Med Genet A       Date:  2013-07-10       Impact factor: 2.802

7.  Down Syndrome Related Muscle Hypotonia: Association with COL6A3 Functional SNP rs2270669.

Authors:  Arpita Dey; Krishnendu Bhowmik; Arpita Chatterjee; Pit Baran Chakrabarty; Swagata Sinha; Kanchan Mukhopadhyay
Journal:  Front Genet       Date:  2013-04-22       Impact factor: 4.599

Review 8.  Dietary Intakes and Nutritional Issues in Neurologically Impaired Children.

Authors:  Francesca Penagini; Chiara Mameli; Valentina Fabiano; Domenica Brunetti; Dario Dilillo; Gian Vincenzo Zuccotti
Journal:  Nutrients       Date:  2015-11-13       Impact factor: 5.717

9.  Digastric Muscle Phenotypes of the Ts65Dn Mouse Model of Down Syndrome.

Authors:  Tiffany J Glass; Nadine P Connor
Journal:  PLoS One       Date:  2016-06-23       Impact factor: 3.240

10.  Oral Function and Eating Habit Problems in People with Down Syndrome.

Authors:  Sonia Cañizares-Prado; Jorge Molina-López; María Trinidad Moya; Elena Planells
Journal:  Int J Environ Res Public Health       Date:  2022-02-24       Impact factor: 3.390

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.